Cancer & SURVIVEiT News

SURVIVEiT One-Of-A-Kind List of Colon Cancer Experts The Top Colon Cancer Doctors

One-Of-A-Kind List of Colon Cancer Experts | The Top Colon Cancer Doctors

October 1, 2021

SURVIVEiT®’s interactive Cancer Navigation Tool was built by survivors and medical experts to help you practically and efficiently navigate cancer care. We took our collective experience and things we wish…

SURVIVEiT Colon Cancer Patient Stories Plus Prevention, Signs & Symptoms

Colon Cancer Patient Stories Plus Prevention, Signs & Symptoms

September 20, 2021

A new Colon Cancer version of SURVIVEiT®’s Cancer Navigation Tool has just been released for colon cancer patients, caregivers and survivors. Our 5-step personalized planning tool was created by cancer…

Media Release SURVIVEiT® LAUNCHES THE CANCER NAVIGATION TOOL

SURVIVEiT® Launches Its Cancer Navigation Tool: Colon Edition

September 14, 2021

First-Ever Interactive Tool Helps Colon Cancer Patients Navigate Their Cancer Journey (Denver, CO, SEPT 14, 2021) – SURVIVEiT®, an organization that envisions a world free from the fear of cancer,…

What Are the Symptoms of Anal Cancer?

March 20, 2020

Part of raising awareness for individual cancer types is increasing awareness of the specific symptoms associated with a given tumor type. For those asking what are the symptoms of anal…

Additional Evidence Found To Connect ctDNA’s Potential Role in Colon Cancer

December 9, 2019

Additional information has been found to show that colon cancer patients with detectable levels of circulating tumor DNA (ctDNA) may be candidates for additional therapy. More Evidence for ctDNA’s Potential…

FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC

September 19, 2019

FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC On August 15, 2019, the Food and Drug Administration granted accelerated approval to entrectinib (ROZLYTREK, Genentech Inc.) for adults and…